Emtricitabine (ID: DG00939) Resistance Data of HIV

Drug Resistance Data Categorized by Their Corresponding Mechanisms
Aberration of the Drug's Therapeutic Target (ADTT)			Click to Show/Hide
Key Molecule: Gag-Pol polyprotein (POL)				Molecule Info
Resistant Disease	Human immunodeficiency virus infection [ICD-11: 1C62.0]
Molecule Alteration	Alteration Patterns Alteration Types Resistance Mutation Total Point Scores Levels of Drug resistance base on the total point score Ref p.M184V+p.M184I Missense mutation N.A. Resistance [1]
Resistant Drug	Emtricitabine			Drug Info
Experimental Note	Discovered Using In-vivo Testing Model
Mechanism Description	Certain amino acid substitutions in the reverse transcriptase of HIV-1 can also reduce susceptibility to emtricitabine (M184V/I) and tenofovir AF (K65R, sometimes plus S68N or L429I; and transiently K70E), although selection of high-level resistance has not occurred with the latter drug over extended periods of culture in vitro.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.